Delivery Order SPE2DB24D2018-SPE2DB25FWUD7
Award Date 4/18/25
Potential Completion Date 4/21/25
Potential Value $2.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $10,140.60 to AmerisourceBergen Drug Corp for 1,440 units/milliliter of HAVRIX vaccine delivered via syringe. This firm fixed price, non-set-aside contract was awarded on July 15, 2025, with an ultimate completion date of July 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. HAVRIX is a hepatitis A vaccine used to support immunization requirements across the Department...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of 1,440 units of HAVRIX 1,440 Unit/mL syringes valued at $1,931.08. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract is scheduled for completion on September 9, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. HAVRIX is a hepatitis A...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,440 units of HAVRIX 1,440 unit/mL syringes valued at $2,311.38. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 30, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,440 units of HAVRIX 1,440 Unit/mL syringe on August 26, 2025, with a ceiling value of $2,017.25 and an ultimate completion date of August 27, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract represents a single transaction for the hepatitis A vaccine product, which will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,012.20 to AmerisourceBergen Drug Corp for HAVRIX 720 Unit/0.5 ML syringes on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. HAVRIX is a hepatitis A vaccine product, reflecting the ongoing federal medical procurement needs for...
- The Defense Logistics Agency awarded a $22,225.50 delivery order to AmerisourceBergen Drug Corp for 1,440 units of Havrix 1-mL syringes on June 6, 2025, with a completion date of June 9, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. Havrix is a hepatitis A vaccine commonly used in military and federal healthcare systems to maintain immunization...
- The Defense Logistics Agency awarded a delivery order valued at $2,501.85 to AmerisourceBergen Drug Corp for the supply of HAVRIX 1,440 UNIT/ML in syringe format. This competitively awarded, firm fixed-price contract was issued on August 27, 2025, with an ultimate completion date of August 28, 2025, and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. HAVRIX is a hepatitis A vaccine commonly utilized by military and federal healthcare systems for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,440 units of Havrix 1 unit/mL syringes valued at $14,927.65 on May 27, 2025, with a completion date of May 28, 2025. This is a firm fixed-price, non-set-aside contract with performance to be completed at AmerisourceBergen's Conshohocken, Pennsylvania facility. Havrix is a hepatitis A vaccine commonly used in military and federal healthcare settings to maintain disease prevention across the armed forces and...
- The Defense Logistics Agency awarded a delivery order valued at $1,597.88 to AmerisourceBergen Drug Corp for 1,440 units/mL of Havrix vaccine in syringes. The contract, awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, utilizes a firm fixed price structure with no set-aside designation. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $10,140.60 to AmerisourceBergen Drug Corp for 1,440 units/mL of Havrix vaccine in syringe form. The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure, with an ultimate completion date of July 21, 2025. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...